Eli Lilly Unusual Options Activity For August 15
Eli Lilly Unusual Options Activity For August 15
High-rolling investors have positioned themselves bearish on Eli Lilly (NYSE:LLY), and it's important for retail traders to take note.\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in LLY often signals that someone has privileged information.
高額投資者已經將自己的看淡頭寸擺好在了Eli Lilly (紐交所:LLY)上，這對零售交易者很重要。這項活動是通過Benzinga跟蹤公開的期權數據發現的。這些投資者的身份尚不確定，但LLY的如此重大舉動通常意味着某人有特權信息。
Today, Benzinga's options scanner spotted 39 options trades for Eli Lilly. This is not a typical pattern.
今日，Benzinga的期權掃描儀發現了39筆Eli Lilly的期權交易。這不是一個典型的模式。
The sentiment among these major traders is split, with 38% bullish and 53% bearish. Among all the options we identified, there was one put, amounting to $42,000, and 38 calls, totaling $5,455,963.
這些主要交易者的情緒是分裂的，38%的人看好，53%的人看淡。在所有我們發現的期權中，有1筆看跌期權，金額爲42,000美元，以及38筆看漲期權，總額爲$5,455,963。
Expected Price Movements
預期價格波動
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $690.0 to $940.0 for Eli Lilly over the last 3 months.
考慮到這些合同的成交量和持倉量，過去3個月內鯨魚們一直在瞄準Eli Lilly的價格區間在690.0美元到940.0美元之間。
Analyzing Volume & Open Interest
分析成交量和未平倉合約
In terms of liquidity and interest, the mean open interest for Eli Lilly options trades today is 480.38 with a total volume of 1,812.00.
就流動性和興趣而言，Eli Lilly期權的平均持倉量是480.38，總成交量爲1,812.00。
In the following chart, we are able to follow the development of volume and open interest of call and put options for Eli Lilly's big money trades within a strike price range of $690.0 to $940.0 over the last 30 days.
在下圖中，我們可以跟隨Eli Lilly大資金交易的看漲和看跌期權的成交量和持倉量的發展，這些期權的執行價格範圍爲690.0美元到940.0美元，持續時間爲30天。
Eli Lilly Option Volume And Open Interest Over Last 30 Days
Eli Lilly過去30天的期權成交量和未平倉合約量
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | SWEEP | BULLISH | 11/15/24 | $236.95 | $234.3 | $237.0 | $700.00 | $2.3M | 756 | 100 |
| LLY | CALL | SWEEP | BULLISH | 09/20/24 | $135.8 | $134.05 | $135.8 | $800.00 | $611.9K | 1.3K | 45 |
| LLY | CALL | SWEEP | BEARISH | 12/19/25 | $183.55 | $176.1 | $176.3 | $900.00 | $125.0K | 498 | 91 |
| LLY | CALL | SWEEP | BEARISH | 12/19/25 | $181.75 | $173.0 | $174.05 | $900.00 | $123.3K | 498 | 1 |
| LLY | CALL | SWEEP | BEARISH | 12/19/25 | $179.7 | $173.05 | $174.05 | $900.00 | $123.0K | 498 | 31 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | 看漲 | SWEEP | 看好 | 11/15/24 | $236.95 | $234.3 | $237.0 | $700.00 | $2.3M | 756 | 100 |
| LLY | 看漲 | SWEEP | 看好 | 09/20/24 | $135.8 | $134.05 | $135.8 | $800.00 | $611.9K | 1.3K | 45 |
| LLY | 看漲 | SWEEP | 看淡 | 2025年12月19日 | $183.55 | $176.1 | $176.3 | $900.00 | $125.0K | 498 | 91 |
| LLY | 看漲 | SWEEP | 看淡 | 2025年12月19日 | $181.75 | $173.0 | $174.05 | $900.00 | $123.3K | 498 | 1 |
| LLY | 看漲 | SWEEP | 看淡 | 2025年12月19日 | $179.7 | $173.05 | $174.05 | $900.00 | $123.0K | 498 | 31 |
About Eli Lilly
關於Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly是一家專注於神經科學，心臟代謝，癌症和免疫學的藥物公司。Lilly的主要產品包括用於治療癌症的Verzenio；用於心臟代謝的Mounjaro，Zepbound，Jardiance，Trulicity，Humalog和Humulin；以及用於免疫學的Taltz和Olumiant。
Current Position of Eli Lilly
Eli Lilly的當前位置
- Currently trading with a volume of 610,194, the LLY's price is down by -0.69%, now at $924.0.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 77 days.
- 目前交易量爲610,194，LLY的股價下跌了-0.69%，現在爲$924.0。
- RSI讀數表明該股目前可能接近超買水平。
- 預期的收益發布還有77天。
What The Experts Say On Eli Lilly
關於Eli Lilly，專家們的看法是什麼？
In the last month, 5 experts released ratings on this stock with an average target price of $1017.0.
上個月，5位專家發佈了對該股票的評級，平均目標價爲1017美元。
- An analyst from B of A Securities persists with their Buy rating on Eli Lilly, maintaining a target price of $1125.
- An analyst from Deutsche Bank upgraded its action to Buy with a price target of $1025.
- An analyst from Berenberg has decided to maintain their Buy rating on Eli Lilly, which currently sits at a price target of $1050.
- An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $885.
- Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Eli Lilly, targeting a price of $1000.
- 來自b of A Securities的分析師堅持對Eli Lilly的買入評級，維持目標價在1125美元。
- 德意志銀行的分析師將其評級上調至買入，目標價爲1025美元。
- 來自Berenberg的分析師決定維持對Eli Lilly的買入評級，目前的價格目標爲1050美元。
- 來自Cantor Fitzgerald的分析師將其評級下調爲Overweight，調整價格目標至885美元。
- Wells Fargo的分析師繼續持有Eli Lilly的增持評級，目標價爲1000美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly options trades with real-time alerts from Benzinga Pro.
期權交易存在更高的風險和潛在回報。精明的交易者通過不斷學習、調整策略、監控多個指標以及密切關注市場動向來管理這些風險。通過來自Benzinga Pro的實時警報，了解最新的Eli Lilly期權交易信息。